Logo image of AG1.DE

AUTO1 GROUP SE (AG1.DE) Stock Fundamental Analysis

FRA:AG1 - Deutsche Boerse Ag - DE000A2LQ884 - Common Stock - Currency: EUR

22.32  -1.06 (-4.53%)

Fundamental Rating

3

Taking everything into account, AG1 scores 3 out of 10 in our fundamental rating. AG1 was compared to 54 industry peers in the Specialty Retail industry. AG1 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AG1 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AG1 has reported negative net income.
In the past year AG1 has reported a negative cash flow from operations.
AG1 had negative earnings in each of the past 5 years.
AG1 had negative operating cash flow in 4 of the past 5 years.
AG1.DE Yearly Net Income VS EBIT VS OCF VS FCFAG1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M

1.2 Ratios

AG1 has a Return On Assets of -2.21%. This is comparable to the rest of the industry: AG1 outperforms 41.51% of its industry peers.
Looking at the Return On Equity, with a value of -7.08%, AG1 is in line with its industry, outperforming 41.51% of the companies in the same industry.
Industry RankSector Rank
ROA -2.21%
ROE -7.08%
ROIC N/A
ROA(3y)-14.8%
ROA(5y)-18.41%
ROE(3y)-32.3%
ROE(5y)-678.61%
ROIC(3y)N/A
ROIC(5y)N/A
AG1.DE Yearly ROA, ROE, ROICAG1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -1K -2K -3K

1.3 Margins

Looking at the Gross Margin, with a value of 10.81%, AG1 is doing worse than 83.02% of the companies in the same industry.
AG1's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AG1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.48%
GM growth 5Y2.6%
AG1.DE Yearly Profit, Operating, Gross MarginsAG1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

More info and screens

5

2. Health

2.1 Basic Checks

AG1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AG1 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AG1 has more shares outstanding
The debt/assets ratio for AG1 is higher compared to a year ago.
AG1.DE Yearly Shares OutstandingAG1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
AG1.DE Yearly Total Debt VS Total AssetsAG1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

AG1 has an Altman-Z score of 4.86. This indicates that AG1 is financially healthy and has little risk of bankruptcy at the moment.
AG1 has a better Altman-Z score (4.86) than 94.34% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that AG1 has dependencies on debt financing.
With a Debt to Equity ratio value of 1.48, AG1 is not doing good in the industry: 77.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Altman-Z 4.86
ROIC/WACCN/A
WACC6.39%
AG1.DE Yearly LT Debt VS Equity VS FCFAG1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M

2.3 Liquidity

AG1 has a Current Ratio of 3.47. This indicates that AG1 is financially healthy and has no problem in meeting its short term obligations.
AG1 has a Current ratio of 3.47. This is amongst the best in the industry. AG1 outperforms 92.45% of its industry peers.
AG1 has a Quick Ratio of 2.14. This indicates that AG1 is financially healthy and has no problem in meeting its short term obligations.
AG1's Quick ratio of 2.14 is amongst the best of the industry. AG1 outperforms 88.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.47
Quick Ratio 2.14
AG1.DE Yearly Current Assets VS Current LiabilitesAG1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

More info and screens

5

3. Growth

3.1 Past

AG1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.14%, which is quite impressive.
AG1 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.54%.
The Revenue has been growing by 13.88% on average over the past years. This is quite good.
EPS 1Y (TTM)87.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
Revenue 1Y (TTM)5.54%
Revenue growth 3Y24.52%
Revenue growth 5Y13.88%
Sales Q2Q%23.73%

3.2 Future

The Earnings Per Share is expected to grow by 40.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.51% on average over the next years. This is quite good.
EPS Next Y103.72%
EPS Next 2Y54.88%
EPS Next 3Y40.53%
EPS Next 5YN/A
Revenue Next Year11.72%
Revenue Next 2Y12.77%
Revenue Next 3Y12.31%
Revenue Next 5Y9.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AG1.DE Yearly Revenue VS EstimatesAG1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
AG1.DE Yearly EPS VS EstimatesAG1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AG1. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 103.64, the valuation of AG1 can be described as expensive.
AG1's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of AG1 to the average of the S&P500 Index (22.10), we can say AG1 is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 103.64
AG1.DE Price Earnings VS Forward Price EarningsAG1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AG1 is valued a bit more expensive than the industry average as 67.92% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 354.55
AG1.DE Per share dataAG1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AG1's earnings are expected to grow with 40.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.88%
EPS Next 3Y40.53%

More info and screens

0

5. Dividend

5.1 Amount

AG1 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUTO1 GROUP SE

FRA:AG1 (3/7/2025, 7:00:00 PM)

22.32

-1.06 (-4.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-07 2025-05-07
Inst Owners50.81%
Inst Owner ChangeN/A
Ins Owners24.47%
Ins Owner ChangeN/A
Market Cap4.86B
Analysts77.78
Price Target23.06 (3.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.6%
Min EPS beat(2)67%
Max EPS beat(2)80.2%
EPS beat(4)3
Avg EPS beat(4)-9.48%
Min EPS beat(4)-235.63%
Max EPS beat(4)80.2%
EPS beat(8)7
Avg EPS beat(8)-0.96%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.53%
Min Revenue beat(2)-0.66%
Max Revenue beat(2)5.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-5.85%
Max Revenue beat(4)5.72%
Revenue beat(8)3
Avg Revenue beat(8)-0.05%
Revenue beat(12)7
Avg Revenue beat(12)2.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)36.38%
PT rev (3m)96.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.05%
EPS NY rev (3m)130.31%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-0.92%
Revenue NY rev (1m)1.3%
Revenue NY rev (3m)5.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.64
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 8.36
P/tB 8.62
EV/EBITDA 354.55
EPS(TTM)-0.09
EYN/A
EPS(NY)0.22
Fwd EY0.96%
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-1.12
OCFYN/A
SpS25.66
BVpS2.67
TBVpS2.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -7.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.81%
FCFM N/A
ROA(3y)-14.8%
ROA(5y)-18.41%
ROE(3y)-32.3%
ROE(5y)-678.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.48%
GM growth 5Y2.6%
F-Score3
Asset Turnover3
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Debt/EBITDA 58.8
Cap/Depr 39.55%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.47
Quick Ratio 2.14
Altman-Z 4.86
F-Score3
WACC6.39%
ROIC/WACCN/A
Cap/Depr(3y)77.9%
Cap/Depr(5y)53%
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
EPS Next Y103.72%
EPS Next 2Y54.88%
EPS Next 3Y40.53%
EPS Next 5YN/A
Revenue 1Y (TTM)5.54%
Revenue growth 3Y24.52%
Revenue growth 5Y13.88%
Sales Q2Q%23.73%
Revenue Next Year11.72%
Revenue Next 2Y12.77%
Revenue Next 3Y12.31%
Revenue Next 5Y9.51%
EBIT growth 1Y83.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year166.14%
EBIT Next 3Y52.65%
EBIT Next 5Y34.67%
FCF growth 1Y-116.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.68%
OCF growth 3YN/A
OCF growth 5YN/A